Creating a vaccine to protect against multiple types of coronaviruses
Developing a Multi-epitope Pan-Coronavirus Vaccine
This study is working on a new vaccine to help protect everyone from different types of coronaviruses, including the one that causes COVID-19, by learning from people who had mild or no symptoms after infection.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California-Irvine NIH-funded |
| Lab location | 1 site (Irvine, United States) |
| Project ID | NIH-11175847 on NIH RePORTER |
What this research studies
This research aims to develop a vaccine that can provide protection against various coronaviruses, including the one responsible for the COVID-19 pandemic. The approach focuses on identifying specific immune responses, such as antibodies and T cells, that are effective in asymptomatic individuals who have been infected. By understanding these immune responses, the researchers hope to create a vaccine that can prevent future coronavirus infections. The study utilizes advanced techniques to identify conserved viral components that can be targeted by the immune system.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who are at risk of coronavirus infections, including those with underlying health conditions or those in high-exposure environments.
Not a fit: Patients who are already immune to coronaviruses or those who have contraindications to vaccination may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a vaccine that significantly reduces the incidence of coronavirus infections and related diseases.
How similar studies have performed: Other research has shown promise in developing vaccines targeting coronaviruses, indicating that this approach has potential for success.
Where this research is happening
Irvine, United States
- University of California-Irvine — Irvine, United States (Active)
Researchers
- Principal investigator: Benmohamed, Lbachir — University of California-Irvine
- Study coordinator: Benmohamed, Lbachir
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.